TY - JOUR
T1 - Pharmacological Approaches to Managing Violence and Aggression in Prison Populations
T2 - Clinical and Ethical Issues
AU - Weightman, Michael
AU - Kini, Ranjit
AU - Parker, Robert
AU - Das, Mrigendra
PY - 2020/11
Y1 - 2020/11
N2 - Violence and aggression are common problems encountered in prison, which frequently require clinical intervention. This increased prevalence is partially attributable to the high morbidity of psychiatric and personality disorders in prison inmates. As prisons are non-therapeutic environments, the provision of clinical care becomes more complex. This article examines the general principles of management of violence and aggression in prison settings, with a particular focus on the clinical and ethical considerations that guide pharmacological approaches. Use of psychotropic medication to address these problems is reserved for situations where there is (i) a diagnosable psychiatric disorder, or (ii) a significant risk of harm to an individual without urgent intervention. Initial focus should be on environmental and behavioural de-escalation strategies. Clear assessment for the presence of major mental illness is crucial, with appropriate pharmacological interventions being targeted and time-limited. Optimising management of any underlying psychiatric conditions is an important preventative measure. In the acute setting, rapid tranquilisation should be performed according to local guidelines with a focus on oral prior to parenteral administration. Clinicians must be mindful of capacity and consent issues amongst prisoners to protect patient rights and guide setting of care.
AB - Violence and aggression are common problems encountered in prison, which frequently require clinical intervention. This increased prevalence is partially attributable to the high morbidity of psychiatric and personality disorders in prison inmates. As prisons are non-therapeutic environments, the provision of clinical care becomes more complex. This article examines the general principles of management of violence and aggression in prison settings, with a particular focus on the clinical and ethical considerations that guide pharmacological approaches. Use of psychotropic medication to address these problems is reserved for situations where there is (i) a diagnosable psychiatric disorder, or (ii) a significant risk of harm to an individual without urgent intervention. Initial focus should be on environmental and behavioural de-escalation strategies. Clear assessment for the presence of major mental illness is crucial, with appropriate pharmacological interventions being targeted and time-limited. Optimising management of any underlying psychiatric conditions is an important preventative measure. In the acute setting, rapid tranquilisation should be performed according to local guidelines with a focus on oral prior to parenteral administration. Clinicians must be mindful of capacity and consent issues amongst prisoners to protect patient rights and guide setting of care.
KW - psychiatric interventions
KW - non-healthcare settings
KW - prisons
KW - Psychotropics
KW - aggression in prison
KW - underlying psychiatric conditions
KW - use of medication in prisoners
UR - http://www.scopus.com/inward/record.url?scp=85089994339&partnerID=8YFLogxK
U2 - 10.1007/s40265-020-01372-2
DO - 10.1007/s40265-020-01372-2
M3 - Article
C2 - 32857359
AN - SCOPUS:85089994339
SN - 0012-6667
VL - 80
SP - 1635
EP - 1647
JO - Drugs
JF - Drugs
IS - 16
ER -